Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB25FEHHZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,992
Award facts
- Contract value 100% obligated
- $36,992.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,992.04 to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injectors on September 10, 2025, with completion scheduled for October 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. BENLYSTA (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus and other autoimmune conditions, and its procurement through DLA supports the pharmaceutical needs of military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial $999.99 billion IDC with DLA Troop Support Medical (SPE2DX) extending through December 2026, which serves as the underlying contract vehicle for this delivery order. The company's comprehensive federal pharmaceutical portfolio demonstrates consistent capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This delivery order exemplifies the company's role as a critical vendor within DLA's pharmaceutical supply chain, fulfilling specialized medical procurement needs for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FEHHZ?
SPE2DB25FEHHZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FEHHZ worth?
The government has obligated $36,992 on SPE2DB25FEHHZ.
Is contract SPE2DB25FEHHZ an order under another contract?
Yes. SPE2DB25FEHHZ is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHHZ competed?
The extent of competition for SPE2DB25FEHHZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award